At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03696 INSILICO
Market Closed 11-13 16:08:17
37.820
-1.340
-3.42%
High39.000
Low37.000
Vol9.41M
Open39.000
D1 Closing39.160
Amplitude5.11%
Mkt Cap22.20B
Tradable Cap22.20B
Total Shares587.00M
T/O356.19M
T/O Rate1.60%
Tradable Shares587.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
InSilico Issues 58.71 Thousand Shares Under Pre-IPO Options and Buys Back 300 Thousand Shares for HK$11.20 Million
Insilico Medicine (03696) Forms AI Drug Development Strategic Partnership with Luoxin Pharmaceutical (002793.SZ), Focusing on Innovative Therapies for Chronic Diseases Including Digestive and Metabolic Conditions
InSilico Medicine Cayman TopCo is a company principally engaged in the artificial intelligence (AI)-driven drug discovery and pipeline development business. The Company mainly self-develops drug candidates, co-develops and partially retains certain intellectual property (IP) rights for out-licensed drugs as well as collaborates with other pharmaceutical companies without retaining any IP rights. The Company generated several clinical or IND-enabling stage assets using its own AI platform under the name of Pharma.AI. The Company is also engaged in software solutions and other discovery business related to non-pharma sectors.